USP’s Sheehan and Liu talk at AAPS PharmSci 360 abou getting novel excipients past the monograph hurdle through early engagement with FDA.
News|Articles|May 30, 2023
Cannabis Science Conference Fall Meeting Issues Call for Abstracts
Author(s)Grant Playter
The next Cannabis Science Conference Fall meeting is soliciting a call for abstracts.
Advertisement
MJH Life Sciences®, parent company of Pharmaceutical Technology® and BioPharm International®, is organizing the next Cannabis Science Conference Fall meeting in Providence, RI, which will run on Sept. 20–22, 2023. The conference is looking for speakers to share their knowledge on a variety of topics including analytical science, medical cannabis, cultivation, and psychedelics.
The event is currently soliciting a call for abstracts. Please submit your talks for consideration to the
Source:
Advertisement
Related to this article
CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
Subathra Ramamoorthy, Veranova, on how forced degradation and trace impurity profiling in potent APIs shape regulator-ready analytical methods.
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
Improving Oral Peptide Delivery Through Structural Modifications
4
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
5